Determining predominating histologic component in malignant mixed mllerian tumors: is it worth it?
Mustafa Özgüroğlu, Ahmet Erkan Bilici, Şennur İlvan et al. · International Journal of Gynecological Cancer · 2007
Cited by 18 works. doi:10.1111/j.1525-1438.2007.01074.x
Authors
References
- Carcinosarcomas and mixed mesodermal tumors of the ovary
- Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma
- Clinicopathologic analysis of uterine malignant mixed müllerian tumors
- A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: A gynecologic oncology group study
- Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus
- Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF Study
- The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus
- Patterns of recurrence in malignant mixed müllerian tumor of the uterus
- Uterine Carcinosarcomas: Incidence and Trends in Management and Survival
- The Role of Whole-Pelvic Irradiation in the Treatment of Early-Stage Uterine Carcinosarcoma